These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation. Husted DS; Shapira NA CNS Spectr; 2004 Nov; 9(11):833-47. PubMed ID: 15520607 [TBL] [Abstract][Full Text] [Related]
4. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment. Hirschtritt ME; Bloch MH; Mathews CA JAMA; 2017 Apr; 317(13):1358-1367. PubMed ID: 28384832 [TBL] [Abstract][Full Text] [Related]
6. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related]
7. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy. Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206 [TBL] [Abstract][Full Text] [Related]
8. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders]. Nakamae T Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of obsessive-compulsive disorder: a review for clinicians. McDonough M; Kennedy N Harv Rev Psychiatry; 2002; 10(3):127-37. PubMed ID: 12023928 [TBL] [Abstract][Full Text] [Related]
11. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity. Brakoulias V Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422 [TBL] [Abstract][Full Text] [Related]
12. Obsessive compulsive disorder (OCD): Current treatments and a framework for neurotherapeutic research. Woody EZ; Hoffman KL; Szechtman H Adv Pharmacol; 2019; 86():237-271. PubMed ID: 31378254 [TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223 [TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapies in the management of obsessive-compulsive disorder. Blier P; Habib R; Flament MF Can J Psychiatry; 2006 Jun; 51(7):417-30. PubMed ID: 16838823 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184 [TBL] [Abstract][Full Text] [Related]
18. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies]. Ammar G; Naja WJ; Pelissolo A Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852 [TBL] [Abstract][Full Text] [Related]